Martek Biosciences Corp.
6480 Dobbin Road
Columbia,
MD 21045
United States - Map
Phone: 410-740-0081
Fax: 410-740-2985
Web Site: http://www.martek.com
| Martek Biosciences Corporation engages in the development and commercialization of novel products from microalgae, fungi, and other microbes in the United States and internationally. Its products include lifesDHA, a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements, and animal feeds; and lifesARA, a vegetarian source of the omega-6 fatty acid ARA (arachidonic acid), for use in infant formula. The companys nutritional oils comprise fatty acid components, such as DHA and ARA, which enhance mental and visual development in infants, as well as enable proper functioning of brain function and reduce the risk of cardiovascular disease. It also provides contract manufacturing services for the production of enzymes, specialty chemicals, vitamins, agricultural specialties, and intermediates. The company sells oils containing fatty acids under the names DHASCO, Neuromins, and ARASCO. Martek Biosciences has a collaboration agreement with a Canadian biotechnology company to co-develop DHA products from plants, as well as an agreement with DSM Food Specialties B.V. for the production and supply of ARA. It also has a joint development agreement with BP plc to work on the production of microbial oils for biofuels applications. The company was founded in 1985 and is based in Columbia, Maryland. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Steve Dubin , 55
Chief Exec. Officer and Exec. Director |
$
1.03M |
$
0 | Mr. David M. Abramson , 56
Pres |
$
797.00K |
$
0 | Mr. Peter L. Buzy , 49
Chief Financial Officer, Principal Accounting Officer, Exec. VP of Fin. & Admin. and Treasurer |
$
797.00K |
$
631.00K | Mr. Peter A. Nitze , 50
Chief Operating Officer and Exec. VP |
$
797.00K |
$
0 | Mr. Barney B. Easterling , 63
Sr. VP of Manufacturing |
$
672.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
Profile
